News

CHDS faculty Eve Wittenberg and James Hammitt discussed how we perceive risks of mask wearing with Sanjay Gupta of CNN as COVID restrictions are relaxed across the US. Wittenberg stressed

Professor Kim Dalziel of the University of Melbourne discussed economic evaluation research conducted alongside clinical trials at the June CHDS research seminar. Head of the Health Economics Unit at

Emily Burger, Harvard T.H. Chan School Research Scientist Associate award-winner, presented at the Spring Research Scientist Seminar Series, May 20, 2021. Burger’s talk presented her recent analysis that quantified

Integrating risk assessment, economic evaluation, and uncertainty to inform policy decisions is a core challenge for decision scientists. Professor John S. Evans is a pioneer in tackling this

Eyal Zimlichman, Sheba Medical Center’s Chief Medical Officer and Chief Innovation Officer, discussed innovations to address the COVID-19 pandemic at the May, 2021 CHDS seminar. Zimlichman presented

The “efficiency” of a program depends on how the benefits and costs are distributed in a population and on the units in which benefits and costs are measured, the so-called “numeraire.” This

With COVID-19 and beyond, advancing toward universal health care will be more difficult for many countries. Local national priority setting is urgently required to provide health

CHDS’ Ankur Pandya and colleagues discuss the distinction between no-value care and low-value care in a recently published article, “Responding to Health-Improving but Cost-Ineffective Care,”

Dr. Mohammad Jalali (‘MJ’), assistant professor at Harvard Medical School and research affiliate with MIT Sloan School, presented his research on modeling the opioid epidemic in the

CHDS faculty Lisa A. Robinson and James K. Hammitt are leading an online professional development workshop, “Benefit-Cost Analysis in Low- and Middle-Income Countries.” The